These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11918281)

  • 1. D-dimer increase after percutaneous transluminal angioplasty and clinical recurrence after primary revascularization in acute myocardial infarction? A pilot study.
    Prisco D; Antonucci E; Fedi S; Margheri M; Giglioli C; Comeglio M; Lombardi A; Chioccioli M; Abbate R; Gensini GF
    Clin Exp Med; 2001 Dec; 1(4):219-24. PubMed ID: 11918281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprocedural PAI-1 activity is a risk marker of subsequent clinical restenosis in patients both with and without stent implantation after elective balloon PTCA.
    Prisco D; Fedi S; Antonucci E; Capanni M; Chiarugi L; Chioccioli M; Falai M; Giglioli C; Abbate R; Gensini GF
    Thromb Res; 2001 Nov; 104(3):181-6. PubMed ID: 11672760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients.
    Prisco D; Fatini C; Battaglini B; Gensini F; Fedi S; Falai M; Chioccioli M; Gori AM; Margheri M; Gensini GF
    Int J Clin Lab Res; 2000; 30(4):179-85. PubMed ID: 11289708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: effects on inflammatory, hemostatic, and endothelium-derived parameters.
    Suzuki S; Matsuo T; Kobayashi H; Matsuo M; Shimamo C; Koide M; Sakamoto S
    Thromb Res; 2000 May; 98(4):269-79. PubMed ID: 10822073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors.
    Saito M; Nakabayashi T; Iuchi K; Ishikawa T; Kaseno K; Yoshida T; Asakura H; Matsuda T
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma plasminogen activator inhibitor-1, tissue plasminogen activator and serum lipoprotein(a) after reperfusion therapy in acute myocardial infarction: comparison between sequential and direct percutaneous transluminal coronary angioplasty.
    Hara M; Ito K; Nawata T; Tsunematsu Y; Shimoyama N; Maeda T; Sato Y; Saikawa T; Sakata T
    Cardiology; 1995; 86(5):407-10. PubMed ID: 7585744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial).
    McBane RD; Hardison RM; Sobel BE;
    Am J Cardiol; 2010 Jan; 105(1):17-24. PubMed ID: 20102884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma urokinase antigen and C-reactive protein predict angina recurrence after coronary angioplasty.
    Parfyonova Y; Alekseeva I; Plekhanova O; Deev A; Titaeva E; Dobrovolsky A; Gabbasov Z; Lyakishev A; Tkachuk V
    Heart Vessels; 2014 Sep; 29(5):611-8. PubMed ID: 24057344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis.
    Strauss BH; Lau HK; Bowman KA; Sparkes J; Chisholm RJ; Garvey MB; Fenkell LL; Natarajan MK; Singh I; Teitel JM
    Circulation; 1999 Oct; 100(15):1616-22. PubMed ID: 10517732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late restenosis after emergent coronary angioplasty for acute myocardial infarction: comparison with elective coronary angioplasty.
    Simonton CA; Mark DB; Hinohara T; Rendall DS; Phillips HR; Peter RH; Behar VS; Kong Y; O'Callaghan WG; O'Connor C
    J Am Coll Cardiol; 1988 Apr; 11(4):698-705. PubMed ID: 2965171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of plasma plasminogen activator inhibitor-1 for coronary restenosis: dependence on stent implantation and antithrombotic medication.
    Christ G; Nikfardjam M; Huber-Beckmann R; Gottsauner-Wolf M; Glogar D; Binder BR; Wojta J; Huber K
    J Thromb Haemost; 2005 Feb; 3(2):233-9. PubMed ID: 15670026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated plasminogen activator inhibitor may prevent late restenosis after coronary stenting in acute myocardial infarction.
    Inoue T; Yaguchi I; Mizoguchi K; Uchida T; Takayanagi K; Hayashi T; Morooka S; Eguchi Y
    Clin Cardiol; 2003 Mar; 26(3):153-7. PubMed ID: 12685623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new thrombolytic agent, monteplase, is independent of the plasminogen activator inhibitor in patients with acute myocardial infarction: initial results of the COmbining Monteplase with Angioplasty (COMA) trial.
    Inoue T; Yaguchi I; Takayanagi K; Hayashi T; Morooka S; Eguchi Y
    Am Heart J; 2002 Oct; 144(4):E5. PubMed ID: 12360174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of intracoronary fibrin degradation after coronary balloon angioplasty.
    Ring ME; Vecchione JJ; Fiore LD; Ruocco NA; Jacobs AK; Deykin D; Ryan TJ; Faxon DP
    Am J Cardiol; 1991 Jun; 67(16):1330-4. PubMed ID: 2042563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
    Tataru MC; Heinrich J; Junker R; Schulte H; von Eckardstein A; Assmann G; Koehler E
    Eur Heart J; 1999 Oct; 20(20):1493-502. PubMed ID: 10493848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infarction. Second Primary Angioplasty in Myocardial Infarction Trial (PAMI-2) Investigators.
    Stone GW; Brodie BR; Griffin JJ; Grines L; Boura J; O'Neill WW; Grines CL
    J Am Coll Cardiol; 2000 Mar; 35(3):605-11. PubMed ID: 10716461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction.
    Barbash GI; Roth A; Hod H; Modan M; Miller HI; Rath S; Zahav YH; Keren G; Motro M; Shachar A
    Am J Cardiol; 1990 Sep; 66(5):538-45. PubMed ID: 2118299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonrandomized comparison between stent deployment and percutaneous transluminal coronary angioplasty in acute myocardial infarction.
    Katz S; Green SJ; Kaplan BM; Chepurko L; Goldner BG; Ong L
    Am Heart J; 2000 Jan; 139(1 Pt 1):44-51. PubMed ID: 10618561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased protein C inhibitor after percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction.
    Tanigawa M; Wada H; Minamikawa K; Wakita Y; Nagaya S; Mori T; Tamaki S; Nishikawa H; Kakuta Y; Nakano T
    Am J Hematol; 1995 May; 49(1):1-5. PubMed ID: 7741129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial changes of plasma plasminogen activator inhibitor activity in acute myocardial infarction: difference between thrombolytic therapy and direct coronary angioplasty.
    Hirashima O; Ogawa H; Oshima S; Sakamoto T; Honda Y; Sakata S; Masuda T; Miyao Y; Yasue H
    Am Heart J; 1995 Nov; 130(5):933-9. PubMed ID: 7484753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.